Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Steadright Files Q1 Interim FS and MD&A / Moroccan Site and Cancellation of Crushing & Grinding Equipment Share Purchase Agreement With Possible Renegotiation
